(NU/1433-47) Kargenera: The Provision of Business Consultancy to Assist Commercialisation of University Research
A Contract Award Notice
by NEWCASTLE UNIVERSITY
- Source
- OJEU
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £30K
- Sector
- BUSINESS
- Published
- 10 Feb 2023
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Newcastle upon Tyne
7 buyers
- Newcastle University Newcastle upon Tyne
- Durham University Stockton Road Durham
- Northumbria University Newcastle Tyne and Wear
- Sunderland University Sunderland
- Teesside University Tees Valley
- Setsquared Bath
1 supplier
- Lifescience Advisors Hughenden Valley
Description
The University of Southampton have developed a unique DNA based therapeutic to activate NK cells against cancer. The therapeutic is delivered intramuscularly in combination with DNA encoding the potent immune stimulating cytokine IL-15. The objective is for an Executive to jointly work with the team to bring the opportunity towards and ultimately achieve launch of a new spinout company.
Total Quantity or Scope
Newcastle, Sunderland, Northumbria, Durham, Teesside universities together with the University of Bath on behalf of the SETsquared Partnership (the Enterprise collaboration of the Universities of Bath, Bristol, Exeter, Southampton and Surrey) and any other HE Institution that wishes to join this DPS, as detailed in the Office for Students Register, https://www.officeforstudents.org.uk/advice-and-guidance/the-register/the-ofs-re... will engage suitably qualified and experienced executives through the DPS as and when required over the DPS period. The specific requirements will be detailed in each individual further competition. The typical brief of an executive will be to: (a) Produce a viable business plan; (b) Obtain university approval for the venture; (c) Act for the company in the spin-out legal process and address all company formation matters; (d) Provide to the appropriate university all matters necessary for Research England and ESIF reporting requirements; (e) Secure (venture capital and/or other) funding in accordance with the business plan. This will be a cyclical process throughout the entire Research England, and potential ESIF project along with any additional funding streams.
Award Detail
1 | Lifescience Advisors (Hughenden Valley)
|
Award Criteria
Ability to meet the required programme | _ |
Quality: Ability to meet the Job Description | 60.0 |
Appointment as COO | _ |
Quality: Ability to meet the Job Description | _ |
Equity | 15.0 |
PRICE | 25.0 |
CPV Codes
- 79410000 - Business and management consultancy services
Indicators
- Award on basis of price and quality.
Legal Justification
This an award from a DPS framework there was no pin and the contract notice was for the overall DPS itself was being rejected when submitting.. Overall Official Journal reference for the overall DPS is OJ S: 2022/S 186-528050. As suggested by the TED Helpdesk we have chosen this route.
Other Information
This an award from a DPS framework there was no pin and the contract notice was for the overall DPS itself. Overall Official Journal reference for the overall DPS is OJ S: 2022/S 186-528050
Reference
- OJEU 084008-2023